Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.
about
Improving survival after endometrial cancer: the big pictureData set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical carePractical issues related to uterine pathology: staging, frozen section, artifacts, and Lynch syndromeFamilial cancer among consecutive uterine cancer patients in Sweden.Molecular profiling of endometrial malignancies.The genetic basis of Lynch syndrome and its implications for clinical practice and risk management.Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic.DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers.Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch Syndrome.Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer casesRelationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomasDifferential Expression and Clinical Significance of DNA Methyltransferase 3B (DNMT3B), Phosphatase and Tensin Homolog (PTEN) and Human MutL Homologs 1 (hMLH1) in Endometrial Carcinomas.High-grade endometrial carcinomas - strategies for typing.Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry.Endometrial stromal sarcoma--the new genetic paradigm.Update on pathology, staging and molecular pathology of endometrial (uterine corpus) adenocarcinoma.The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century.New use of microsatellite instability analysis in endometrial cancer.Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials.Current Lynch syndrome tumor screening practices: a survey of genetic counselors.The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future.Genomic profiling identifies GPC5 amplification in association with sarcomatous transformation in a subset of uterine carcinosarcomas.A guided tour of selected issues pertaining to metastatic carcinomas involving or originating from the gynecologic tract.Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model.Targeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer.Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
P2860
Q26801354-65A3DB7A-7112-4639-B814-30DC39FCD9A1Q26852127-B4D4436D-34E6-4F87-913C-B98A6CDBC955Q28078792-2F1ECE3E-97F8-4736-B51C-810F18D54A23Q28080146-F515E343-7451-474E-8EFB-536387C720E6Q33646157-27F16A30-8002-4A87-894C-C07A5DEA4D88Q33757898-A9478714-5431-48DC-AC5E-871C91FCC321Q34081267-4FAD4119-F8E6-4C2B-AE4A-2D67E023F7F7Q34591199-D9759F15-8D63-475E-9003-4CCA3DC93576Q34996982-8910D172-A860-4541-9438-089924529C3CQ35084724-8DD564E0-AC6A-44E7-AD38-6247827D2B8CQ36094483-EA025BFD-6EF6-4602-BC95-901556086669Q37038863-48B2A1C8-9646-4ACA-80EA-2B17040C8623Q37673879-06D8A088-4948-45A6-881A-1160477C8215Q38067439-7D7CBBED-4944-4305-B03B-28875B30C98AQ38084166-FCF8F32B-8C55-4DF3-A2C5-F13621C1FBA1Q38263798-43260B82-1B88-46E9-8C3E-939386A191C1Q38628862-5DB4B4E3-DE4C-44C4-BFB6-2A2A1931139AQ39037647-4A0B1D4F-CBCD-4B00-8013-8903C67C40A3Q41619058-914B6AA1-ED5C-4D73-A5C6-F3DE8E8F9115Q45848384-FA7666F4-120E-4648-AAFF-642C92A16FE2Q45898127-12064827-4DD0-4112-9C1B-E903A4E0CB08Q47299584-7E8BD13C-519C-40A9-BC3F-0C9948FA87CDQ49211814-D775AE07-652E-4738-BBAF-D918A4B4E379Q49724000-CFDC5C92-6F53-42A9-B9A9-B6F015DDCAF0Q50020665-8C0E1FBB-51C6-490E-9FF7-A182B1CEF369Q50720259-C6EB70E3-FB8C-4559-B5BC-B97F0A34DD12Q51552333-FA57E6BD-C373-4865-B78E-8FE9CB2B8DE9
P2860
Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.
@ast
Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.
@en
type
label
Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.
@ast
Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.
@en
prefLabel
Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.
@ast
Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.
@en
P356
P1476
Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma
@en
P2093
P304
P356
10.1136/JCP.2009.064949
P407
P577
2009-08-01T00:00:00Z